Explore more publications!

Press Releases

UPDATED: From Screen to Plate: CJ Foods’ Cuisine. K Brings the Magic of Netflix Hit ‘Bon Appétit, Your Majesty’ to U.S. Kitchens
Nitric Boost Ultra Claims Evaluated: The Ultra Nitric Oxide Booster for Men's Performance Enhancement
EverPass Media Expands Relationship with Netflix; Secures Exclusive Commercial Rights to Distribute Upcoming Fury vs. Makhmudov Fight in the U.S.
Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications
From Screen to Plate: CJ Foods’ Cuisine. K Brings the Magic of Netflix Hit ‘Bon Appétit, Your Majesty’ to U.S. Kitchens
Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
U.S. Labor Market Shows Cooling Trends

U.S. Labor Market Shows Cooling Trends

28th OUTshine LGBTQ+ Film Festival Spring Ed. Offers International, N. American & East Coast Premieres  April 23 – May 3
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
Largest U.S. Event Dedicated to Food Hall Operations Nears Sellout
Global Blockchain Food Traceability Market to Reach USD 69.22B by 2036, Asia Pacific Dominance | IBM Food Trust, Dock
JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)
Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
U Chiang Mai Hotel Honors the Past  With Eyes Fixed on a Greener Future
U.S. Ambulatory Surgery Center Market Analysis of Size, Shares, Business Growth, and Upcoming Trends Forecast 2026-2033
Meridian Rapid Defense Group Opens New Central U.S. Operations Hub in Hutto, Texas
i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD
Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1
Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory  Idiopathic Intracranial Hypertension (IIH)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions